telehealth glp-1 crackdown news The FDA is cracking down on ‘misleading’ compounded GLP-1s from companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, FDA takes aim at telehealth

2023;619(7969):371-377.[DOI] 83

Introduction Oxidative stress is one of the main causes of the development of different types of diseases, such as cancer [ 1 , 2 ], neurodegenerative pathologies [ 3 , 4 ], liver [ 5 , 6 ], cardiac [ 7 , 8 ], pulmonary [ 9 , 10 ] and renal diseases [ 11 , 12 ]

Gonadotropins, including gonadotropin releasing hormone (GnRH), LH, FSH, and human chorionic gonadotropin (hCG) (a hormone with LH-like effects), are approved for use in treating infertility due to hypogonadotropic hypogonadism

GLP-1 medications also appear to decrease these inflammatory signals, which may explain why some patients see improvements in their skin conditions while on the drug